Piramal Pharma LimitedNSE: PPLPHARMA

Press Release Jan 28 2025

· Issued by Piramal Pharma Limited

Filed with NSE · · 25 pages · English

Summary by 6ix AI

Piramal Pharma Limited has announced its financial results for the third quarter and nine months of the fiscal year, highlighting significant revenue growth and operational achievements. The company reported a notable increase in revenue driven by its Contract Development and Manufacturing Organization and Complex Hospital Generics segments. Additionally, Piramal Pharma has made strides in sustainability by converting a coal-fired steam boiler to a biomass briquette system, significantly reducing greenhouse gas emissions. The results reflect a strong performance across various business segments, with a focus on innovation and market expansion.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Piramal Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "Press Release Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2024".

Piramal Pharma Limited on 6ix

In the deck

Earlier from Piramal Pharma

Later from Piramal Pharma

All Piramal Pharma news releases